Select language:  
1800 620 420
Close menu

Learning to live around our grief

Grief is very much part of our lives - it’s not something separate and it's not just about dying or death, it's around endings, according to psychotherapist, Dr Stephanie Thompson.  

  • Grief and loss
  • Treatments and side-effects
Read more
Dr Stephanie Thompson

Expert Series: the healing power of music therapy

“Music is very much part of our lives” and that's why it's such a useful and effective tool in therapy, according to Tasmanian registered music therapist, Dr Stephanie Thompson. 

  • Grief and loss
  • Interviews with experts
  • Treatments and side-effects
Read more
Dr Stephanie Thompson

Increased melanoma risk in CLL patients means regular skin checks critical

People with chronic lymphocytic leukaemia (CLL) have a sizeable 600% higher risk of the most dangerous form of skin cancer, melanoma, researchers have found.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Skin check

Being immunocompromised makes CLL patients one of the most vulnerable patient groups

Clinical haematologist and researcher, Associate Professor Nada Hamad discusses the latest on CLL.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Diana Brown

Don had a stem cell transplant at 70 and says “exercise helped”

Don Hayes had an allogeneic stem cell transplant days before his 71st birthday.

  • Myelodysplastic syndromes
  • Research
  • Treatments and side-effects
Read more

PBAC considering selinexor for a third time

For the third time, selinexor (Xpovio®) will be considered by the Pharmaceutical Benefits Advisory Committee (PBAC) at its November 2022 meeting for the treatment of relapsed/refractory (R/R) myeloma. 

  • Myeloma
  • Treatments and side-effects
Read more

PBAC recommends daratumumab for newly diagnosed AL amyloidosis

Daratumumab (Darzalex®) could be the first ever therapy to be approved in Australia for AL amyloidosis.

  • Amyloidosis
  • Treatments and side-effects
Read more
Daratumumab

New targeted treatment option available for Waldenström macroglobulinemia (WM) patients through PBS.

The Leukaemia Foundation has welcomed news that for the first time, a targeted treatment option will now be available for Waldenström macroglobulinemia (WM) patients through the Pharmaceutical Benefits Scheme (PBS).

  • Other blood cancers
  • Treatments and side-effects
Read more

Patients retain remission for 10+ years after CAR T-cell therapy

It’s 10 years since the first CLL patients were treated with CAR T-cell therapy and they are still in remission.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Illustration of various treatments, pills, medicines

Jane’s had three different cancer diagnoses in two years

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes
  • Treatments and side-effects
Read more
Jane Alder and Violet